VVX · XBRL financial data

V2X financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (VVX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026	Q3 FY26Oct 2, 2026
Revenue from contracts with customers	1,040*	1,011	1,072	1,082	1,158*	1,016	1,078	1,167	1,219*	1,254	1,257	1,271
Cost of goods and services sold	942*	940	998	990	1,050*	938	983	1,073	1,114*	1,148	1,147	1,168
Selling, general and administrative	59*	40	46	42	56*	44	43	39	54*	62	56	44
Other operating income (expense)	(2)*	(2)	(5)	(3)	(1)*	(2)	(3)	(3)	(3)*	(2)	(2)	(2)
Operating income (loss)	39*	30	27	50	52*	34	53	56	51*	44	54	59
Income tax expense (benefit)	8*	(0)	(2)	4	1*	2	7	8	6*	5	8	10
Net income (loss)	(0)*	1	(7)	15	25*	8	22	25	23*	19	26	32
Earnings per share, basic USD per share	(0.02)*	0.04	(0.21)	0.48	0.79*	0.26	0.71	0.78	0.73*	0.61	0.82	1.02
Earnings per share, diluted USD per share	(0.02)*	0.04	(0.21)	0.47	0.77*	0.25	0.70	0.77	0.72*	0.60	0.81	1.01
Weighted average shares, basic millions of shares	31*	31	31	32	32*	32	32	32	31*	31	31	31
Weighted average shares, diluted millions of shares	31*	32	31	32	33*	32	32	32	32*	32	32	32

Fiscal quarters (VVX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026	Q3 FY26Oct 2, 2026
Cash and cash equivalents	73	36	45	60	268	169	190	182	369	209	214	265
Inventory	47	—	47	50	51	50	50	48	46	49	59	63
Prepaid and other current assets	49	129	150	156	71	128	138	143	127	132	164	173
Total current assets	875	954	977	982	1,100	1,003	1,067	1,099	1,235	1,169	1,205	1,248
Property and equipment, net	85	93	70	66	62	60	61	58	52	51	49	48
Right-of-use asset	41	38	36	33	38	37	34	38	29	—	—	—
Goodwill	1,657	1,648	1,656	1,653	1,657	1,657	1,657	1,677	1,677	1,677	1,677	1,677
Total assets	3,082	3,140	3,151	3,126	3,229	3,103	3,146	3,178	3,281	3,189	3,198	3,218
Accounts payable	453	431	462	538	548	441	435	487	557	467	547	468
Accrued liabilities	214	267	242	235	262	282	287	255	267	281	217	270
Current portion of long-term debt	15	15	17	17	20	20	15	15	15	15	16	18
Total current liabilities	840	853	888	906	996	867	887	914	1,016	933	914	918
Long-term debt	1,100	1,154	1,142	1,097	1,087	1,090	1,092	1,089	1,083	1,061	1,048	1,034
Lease liability, non-current	35	32	32	30	34	32	30	33	30	—	—	—
Total liabilities	2,091	2,146	2,159	2,124	2,203	2,068	2,080	2,098	2,196	2,086	2,064	2,047
Retained earnings	231	232	225	241	266	274	296	321	343	362	388	420
Total stockholders' equity	991	994	992	1,003	1,026	1,036	1,066	1,080	1,085	1,104	1,134	1,171
Total liabilities and equity	3,082	3,140	3,151	3,126	3,229	3,103	3,146	3,178	3,281	3,189	3,198	3,218
Common shares outstanding (cover page) millions of shares	31	31	32	32	32	32	32	32	31	31	31	31

Fiscal quarters (VVX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026	Q3 FY26Oct 2, 2026
Net income (loss)	(0)*	1	(7)	15	25*	8	22	25	23*	19	26	32
Stock-based compensation	6*	5	7*	1*	3*	2	4*	3*	3*	4	5*	3*
Net cash from operating activities	53*	(57)	26*	63*	223*	(95)	29*	39*	209*	(130)	22*	67*
Net cash from investing activities	(7)*	(25)	(1)*	(2)*	(1)*	(3)	(2)*	(30)*	5*	(2)	(1)*	(3)*
Share repurchases	year only	—	—	—	0*	—	—	—	20*	—	—	—
Proceeds from long-term debt	0*	0	0*	0*	0*	—	—	—	year only	—	—	—
Repayments of long-term debt	4*	4	4*	0*	8*	0	4*	4*	7*	24	14*	14*
Net cash from financing activities	(55)*	46	(15)*	(48)*	(8)*	(4)	(7)*	(13)*	(28)*	(28)	(15)*	(14)*
Net change in cash	(6)*	(37)	9*	15*	208*	(99)	21*	(8)*	187*	(160)	6*	51*

SIC 8744 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8744 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
V2X	265	1,271	67*	31.4M	—	Q3 FY26 10-QOct 2, 2026
Onterris	13	187	6.2*	35.1M	—	Q2 FY26 10-QJun 30, 2026
TSS	68	35	7.6*	28.2M	—	Q2 FY26 10-Q/AJun 30, 2026
Astrana Health	401	973	33*	55.7M	—	Q2 FY26 10-QJun 30, 2026
Hackett Group	14	69	15*	24.9M	—	Q2 FY26 10-QJun 26, 2026
Bowman Consulting Group	10	146	(7.9)*	17.3M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
Evolent Health	116	653	(9.3)*	113.1M	12.4 quarters	Q2 FY26 10-QJun 30, 2026
Franklin Covey	12	68	1.1*	11.3M	—	Q3 FY26 10-QMay 31, 2026
ICF International	4.6	474	100*	17.9M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.